共 125 条
[1]
Bruke MS(2007)Herpes zoster vaccine: clinical trial evidence and implications for medical practice J Am Osteopath Assoc 107 S14-S18
[2]
Harpaz R(2008)Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 57 1-30
[3]
Ortega-Sanchez IR(2004)What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 4 26-33
[4]
Seward JF(2014)Systematic review of incidence and complications of herpes zoster: towards a global perspective BMJ Open 4 e004833-20
[5]
Thomas SL(2015)Herpes zoster vaccination in the elderly subjects: improving awareness and uptake Patient Intell 7 15-215
[6]
Hall AJ(2009)Overview of vaccination policies for the elderly in Western European countries Aging Clin Exp Res 21 210-765
[7]
Kawai K(2015)Functional decline and herpes zoster in older people: an interplay of multipe factors Aging Clin Exp Res 27 757-451
[8]
Gebremeskel BG(2012)The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries J Public Health 20 441-354
[9]
Acosta CJ(2002)Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy Clin J Pain 18 350-570
[10]
Stefanati A(2013)Herpes zoster eye complications: rates and trends Mayo Clin Proc 88 562-759